Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides
出版年份 2018 全文链接
标题
Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides
作者
关键词
-
出版物
CLINICAL PHARMACOKINETICS
Volume 57, Issue 7, Pages 797-816
出版商
Springer Nature
发表日期
2018-01-13
DOI
10.1007/s40262-017-0623-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Review of the pharmacokinetics of dalbavancin, a recently approved lipoglycopeptide antibiotic
- (2017) Ranjeet Prasad Dash et al. Infectious Diseases
- Tissue pharmacokinetics of telavancin in healthy volunteers: a microdialysis study
- (2016) Peter Matzneller et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Therapeutic drug monitoring of vancomycin: a guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society
- (2016) Zhi-Kang Ye et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Systematic Review and Meta-Analysis of the Efficacy and Safety of Telavancin for Treatment of Infectious Disease: Are We Clearer?
- (2016) Junlan Chuan et al. Frontiers in Pharmacology
- Kidney Injury Associated with Telavancin Dosing Regimen in an Animal Model
- (2015) Vincent H. Tam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects
- (2015) Patrick J. Scoble et al. CLINICAL DRUG INVESTIGATION
- Oritavancin: A Long-Half-Life Lipoglycopeptide
- (2015) Louis D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- Telavancin: The Long and Winding Road From Discovery to Food and Drug Administration Approvals and Future Directions
- (2015) Eric Wenzler et al. CLINICAL INFECTIOUS DISEASES
- Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing method
- (2015) Rodrigo E. Mendes et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Pharmacokinetics of intravenous telavancin in healthy subjects with varying degrees of renal impairment
- (2015) Philip D. Worboys et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Vancomycin Tissue Pharmacokinetics in Patients with Lower-Limb Infections via In Vivo Microdialysis
- (2015) Seth T. Housman et al. JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION
- Novel antibody–antibiotic conjugate eliminates intracellular S. aureus
- (2015) Sophie M. Lehar et al. NATURE
- Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates
- (2015) Shanshan Zhang et al. PLoS One
- Revised Reference Broth Microdilution Method for Testing Telavancin: Effect on MIC Results and Correlation with Other Testing Methodologies
- (2014) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae byIn VitroTime-Kill Experiments
- (2014) T. Tängdén et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phagocytosis of Staphylococcus aureus by Human Neutrophils Prevents Macrophage Efferocytosis and Induces Programmed Necrosis
- (2014) M. C. Greenlee-Wacker et al. JOURNAL OF IMMUNOLOGY
- The first report of the vanC1 gene in Enterococcus faecium isolated from a human clinical specimen
- (2014) Mingyue Sun et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- Comparative Activities of Telavancin Combined with Nafcillin, Imipenem, and Gentamicin against Staphylococcus aureus
- (2013) Steven N. Leonard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin AUC/MIC Ratio and 30-Day Mortality in Patients with Staphylococcus aureus Bacteremia
- (2013) Natasha E. Holmes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study
- (2013) G. G. Zhanel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Presence of the Vancomycin Resistance Gene Cluster vanC1, vanXYc, and vanT in Enterococcus casseliflavus
- (2013) Christina Hölzel et al. Microbial Drug Resistance
- Further Insights into the Mode of Action of the Lipoglycopeptide Telavancin through Global Gene Expression Studies
- (2012) Yang Song et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- d-Ala-d-Ser VanN-Type Transferable Vancomycin Resistance in Enterococcus faecium
- (2011) François Lebreton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization
- (2011) Jack Brown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mass Balance and Pharmacokinetics of [14C]Telavancin following Intravenous Administration to Healthy Male Volunteers
- (2010) J.-P. Shaw et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Specificity of Induction of the vanA and vanB Operons in Vancomycin-Resistant Enterococci by Telavancin
- (2010) C. M. Hill et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antistaphylococcal Activities of Telavancin Tested Alone and in Combination by Time-Kill Assay
- (2010) G. Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Telavancin Studied in anIn VitroPharmacokinetic Model of Infection
- (2010) Alasdair P. MacGowan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Microbial Etiologies of Hospital‐Acquired Bacterial Pneumonia and Ventilator‐Associated Bacterial Pneumonia
- (2010) Ronald N. Jones CLINICAL INFECTIOUS DISEASES
- Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
- (2010) E. Rubinstein et al. CLINICAL INFECTIOUS DISEASES
- Effect of Telavancin on the Pharmacokinetics of the Cytochrome P450 3A Probe Substrate Midazolam: A Randomized, Double-Blind, Crossover Study in Healthy Subjects
- (2010) Shekman L Wong et al. PHARMACOTHERAPY
- Intracellular Activity of Antibiotics in a Model of Human THP-1 Macrophages Infected by a Staphylococcus aureus Small-Colony Variant Strain Isolated from a Cystic Fibrosis Patient: Study of Antibiotic Combinations
- (2009) H. A. Nguyen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Telavancin against Staphylococcus aureus Strains with Various Vancomycin Susceptibilities in an In Vitro Pharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations
- (2009) S. N. Leonard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Lack of Pharmacokinetic Drug Interactions Following Concomitant Administration of Telavancin with Aztreonam or Piperacillin/Tazobactam in Healthy Participants
- (2009) Shekman L. Wong et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics of Dalbavancin in Patients With Renal or Hepatic Impairment
- (2009) Thomas Marbury et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Therapeutic Monitoring of Vancomycin in Adults
- (2009) Michael J Rybak et al. PHARMACOTHERAPY
- Telavancin Penetration into Human Epithelial Lining Fluid Determined by Population Pharmacokinetic Modeling and Monte Carlo Simulation
- (2008) T. P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States
- (2008) D. C. Draghi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006
- (2008) D. M. Sievert et al. CLINICAL INFECTIOUS DISEASES
- Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms
- (2008) Martin E. Stryjewski et al. CLINICAL INFECTIOUS DISEASES
- Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis
- (2008) S. Lemaire et al. CLINICAL MICROBIOLOGY AND INFECTION
- Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts)
- (2008) M. Barcia-Macay et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search